EFFICACY OF ADD - ON VILDAGLIPTIN THERAPY TO METFORMIN FOR TYPE II DIABETES MELLITUS PATIENTS IN SOUTH INDIAN RESOURCE LIMITED SETTINGS - PILOT STUDY

被引:0
|
作者
Vigneshwaran, E. [1 ]
Venkatesh, K. [1 ]
Kirankumar, C. [1 ]
Rubiya, S. [1 ]
Padmanabhareddy, Y. [1 ]
Achar, B. [2 ]
机构
[1] Raghavendra Inst Pharmaceut Educ & Res, Anantapur, Andhra Pradesh, India
[2] Govemment Med Coll, Anantapur, Andhra Pradesh, India
关键词
D O I
10.1016/j.jval.2014.08.142
中图分类号
F [经济];
学科分类号
02 ;
摘要
PDB4
引用
收藏
页码:A741 / A741
页数:1
相关论文
共 50 条
  • [21] Efficacy and safety of combination therapy with vildagliptin and metformin versus metformin up-titration in Chinese patients with type 2 diabetes mellitus: study design and rationale of the vision study
    Ji, Li-Nong
    Pan, Chang-Yu
    Lu, Ju-Ming
    Li, Hong
    Li, Qiang
    Li, Qi-Fu
    Peng, Yong-De
    Tian, Hao-Ming
    Yao, Chen
    Zhao, Zhi-Gang
    Zhang, Ru-Ya
    Wang, Xiang-Ling
    Wang, Lei
    CARDIOVASCULAR DIABETOLOGY, 2013, 12
  • [22] Efficacy and safety of combination therapy with vildagliptin and metformin versus metformin up-titration in Chinese patients with type 2 diabetes mellitus: study design and rationale of the vision study
    Li-Nong Ji
    Chang-Yu Pan
    Ju-Ming Lu
    Hong Li
    Qiang Li
    Qi-Fu Li
    Yong-De Peng
    Hao-Ming Tian
    Chen Yao
    Zhi-Gang Zhao
    Ru-Ya Zhang
    Xiang-Ling Wang
    Lei Wang
    Cardiovascular Diabetology, 12
  • [23] ECONOMIC EVALUATION OF VILDAGLIPTIN COMPARED TO GLIMEPIRIDE AS ADD-ON TO METFORMIN FOR THE TREATMENT OF DIABETES MELLITUS TYPE 2 PATIENTS IN GREECE
    Hatzikou, M.
    Rombopoulos, G.
    Yfantopoulos, J.
    VALUE IN HEALTH, 2012, 15 (07) : A501 - A501
  • [24] Efficacy and safety of add on therapy of bromocriptine with metformin in Indian patients with type 2 diabetes mellitus: A randomized open labeled phase IV clinical trial
    Ghosh, Arijit
    Sengupta, Nilanjan
    Sahana, Pranab
    Giri, Debasis
    Sengupta, Parama
    Das, Nina
    INDIAN JOURNAL OF PHARMACOLOGY, 2014, 46 (01) : 24 - 28
  • [25] Vildagliptin Efficacy in Combination with MetfoRmIn for EarlY Treatment of Type 2 Diabetes Mellitus (VERIFY)
    Sheu, Wayne Huey-Herng
    Prato, Stefano D.
    Foley, James
    Kothny, Wolfgang
    Kozlovski, Plamen
    Paldanius, Paeivi
    Stumvoll, Michael
    Matthews, David R.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 254 - 255
  • [26] Better adherence with vildagliptin add-on to metformin than sulphonylurea add-on to metformin among Muslim patients with type 2 diabetes mellitus fasting during Ramadan
    Hanif, W.
    Malik, W.
    Hassanein, M.
    Kamal, A.
    Geransar, P.
    Lister, N.
    Andrews, C.
    Barnett, A. H.
    DIABETOLOGIA, 2011, 54 : S342 - S342
  • [27] Cost effectiveness of vildagliptin versus glimepiride as add-on treatment to metformin for the treatment of diabetes mellitus type 2 patients in Greece
    Hara Kousoulakou
    Magdalini Hatzikou
    Varvara Baroutsou
    John Yfantopoulos
    Cost Effectiveness and Resource Allocation, 15
  • [28] Long-term efficacy and safety of add-on therapy of vildagliptin in type 2 diabetes mellitus with insulin treatment
    Kanazawa, Ippei
    Tanaka, Ken-ichiro
    Notsu, Masakazu
    Tanaka, Sayuri
    Kiyohara, Nobuaki
    Koike, Sayo
    Yamane, Yuko
    Tada, Yuko
    Sasaki, Motofumi
    Yamauchi, Mika
    Sugimoto, Toshitsugu
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S107 - S107
  • [29] Real-World Observational Study on Vildagliptin With Insulin (VIL-INS) or Vildagliptin and Metformin With Insulin (VIL-MET-INS) Therapy in Indian Patients With Type 2 Diabetes Mellitus
    Panneerselvam, P.
    Biswas, Dibakar
    Singh, Hema
    Kumar, K. Dilip
    Kumar, P. Ravi
    Kalra, Pramila
    Revankar, Santosh
    Warrier, Sona
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
  • [30] Efficacy and safety of vildagliptin in patients with type 2 diabetes mellitus inadequately controlled with dual combination of metformin and sulphonylurea
    Lukashevich, V.
    Prato, S. D.
    Araga, M.
    Kothny, W.
    DIABETES OBESITY & METABOLISM, 2014, 16 (05): : 403 - 409